They are very competent. As you probably know, Tom was...

They are very competent. As you probably know, Tom was responsible for the Sirtex deal - i.e., the sale to Chinese private equity firm CDH Investments - which I think is still the largest M&A in Australian biotech history. And interestingly, the subsidiary to CDH - China Grand Pharma - recently bought (and sold at a large profit) a large stake in another ASX-listed biotech - Telix Pharmaceuticals. This isn't surprising, given that some of the Sirtex crew ended up at Telix. My point is that, IMO, CDH/CGP will be looking closely at IXC down the track. They're clearly interested in investing in Australian biotechs and they have dealt with Tom before. Time will tell